However, even though we cannot yet determine whether an increase in CDA activity/expression in the blood of patients with breast cancer is of clinical/therapeutic interest for patients, we believe that our results are highly original and open up interesting perspectives for new functional studies. This evidence concerns the gene CDA and breast cancer.